Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


Atlas Hires Senior Technical Consultant

Atlas Material Testing Technology (Chicago, IL, http://www.atlas-mts.com/) named David Dumbleton its senior technical consultant for the newly created Atlas Consulting Group. Dumbleton will lend his expertise in environmental durability and performance to Atlas's customers and expand the North American consultingservices group.

Dumbleton's experience includes technical and business management in the polymer-materials industry. He previously worked as a director of research and development at Alcoa Flexible Packaging.

Expansions

BASF Adds THF Capacity at Ludwigshafen Site

BASF (Florham Park, NJ http://www.basf.com/) is expanding its annual capacity for the intermediate tetrahydrofuran (THF) by 30, 000 tons at its Ludwigshafen site. The expansion will raise the company's annual THF capacity to 210, 000 metric tons by the end of 2007.

THF is used in complex water-sensitive reactions frequently needed to produce active pharmaceutical ingredients. BASF supplies high-purity THF with a low residual water content of 0.01%.

Future Pak Moves to Larger Facility

Future Pak Ltd. (Wixom, MI, http://www.futurepak.com/), a contract packager, moved its solid-dose packaging operations to a new location. Three blister suites, 12 form–fill–seal lines, and soliddose bottling operations moved to a 32, 000-ft2 facility in Wixom, Michigan.

The site will provide space for the expansion of the company's blister-packaging capacity. During the past three years, Future Pak's annual packaging volume grew to 1800 batches, or about 7 billion tablets.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here